CFA
AMPH icon

Carroll Financial Associates’s Amphastar Pharmaceuticals AMPH Stock Holding History

Carroll Financial Associates’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-85
Closed -$1K – 1608
2021
Q3 		$1K Buy
+85
New +$1.67K ﹤0.01% 1602

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Carroll Financial Associates's AMPH Position: Q4 2021 in Review

Carroll Financial Associates sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2021, closing a stake of 85 shares — an estimated $1K sold.

Carroll Financial Associates first reported a position in AMPH in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 168 funds tracked by Wall St. Rank hold AMPH as of Q4 2021.

  • Carroll Financial Associates reported no remaining Amphastar Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Carroll Financial Associates sold 85 Amphastar Pharmaceuticals shares in Q4 2021, an estimated $1K.
  • Carroll Financial Associates first reported a position in Amphastar Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • Carroll Financial Associates's Amphastar Pharmaceuticals position peaked at $1K in Q3 2021.
  • 168 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.